Farshad Guirakhoo Joins Vaxess Technologies As Chief Technology Officer

Former Hookipa Biotech CSO and Sanofi/Acambis veteran to lead development of silk-based vaccine stabilization technology June 30, 2014 Vaxess Technologies, Inc., an innovative life sciences company developing a novel vaccine stabilization technology, announced today the addition of Farshad Guirakhoo, PhD, to its leadership team as Chief Technology Officer. Vaxess’s proprietary platform harnesses the unique properties of fibroin, a protein derived …

Thomas Monath And Russell Middaugh Join Scientific Advisory Board Of VAXESS Technologies

Innovative vaccine stabilization company adds experts with extensive experience in vaccine development and formulation April 4, 2014 Vaxess Technologies, Inc., an innovative life sciences company developing a novel vaccine stabilization technology, announced today the addition of two new members to the company’s scientific advisory board: Thomas Monath, MD, and Russell Middaugh, PhD. Dr. Monath and Dr. Middaugh will be instrumental …